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Background: Brucellosis caused by Brucella abortus is one of the most important zoonoses in the world.
Multiple-locus variable-number tandem repeat analysis (MLVA16) has been shown be a useful tool to epidemiological
traceback studies in B. abortus infection. Thus, the present study aimed (i) to evaluate the genetic diversity of B. abortus
isolates from a brucellosis outbreak, and (ii) to investigate the in vivo stability of the MLVA16 markers.
Results: Three-hundred and seventy-five clinical samples, including 275 vaginal swabs and 100 milk samples, were
cultured from a brucellosis outbreak in a cattle herd, which adopted RB51 vaccination and test-and-slaughter
policies. Thirty-seven B. abortus isolates were obtained, eight from milk and twenty-nine from post-partum/abortion
vaginal swabs, which were submitted to biotyping and genotyping by MLVA16. Twelve B. abortus isolates obtained
from vaginal swabs were identified as RB51. Twenty four isolates, seven obtained from milk samples and seventeen
from vaginal swabs, were identified as B. abortus biovar 3, while one isolate from vaginal swabs was identified as
B. abortus biovar 1. Three distinct genotypes were observed during the brucellosis outbreak: RB observed in all isolates
identified as RB51; W observed in all B. abortus biovar 3 isolates; and Z observed in the single B. abortus biovar 1 isolate.
Epidemiological and molecular data show that the B. abortus biovar 1 genotype Z strain is not related to the B. abortus
biovar 3 genotype W isolates, and represents a new introduction B. abortus during the outbreak.
Conclusions: The results of the present study on typing of multiple clinical B. abortus isolates from the same outbreak
over a sixteen month period indicate the in vivo stability of MLVA16 markers, a low genetic diversity among B. abortus
isolates and the usefulness of MLVA16 for epidemiological studies of bovine brucellosis.
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Brucellosis is a bacterial disease caused by microorgan-
isms of the genus Brucella that affects different live-
stock and wild animal species, besides man [1]. Cattle
are the preferred host of Brucella abortus and the eco-
nomic importance attributed to bovine brucellosis is
based on losses caused by abortions, stillbirths, weight
loss, decreased milk production and the establishment* Correspondence: alage@vet.ufmg.br
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Because direct and indirect losses triggered by B. abortus
infection, the control and eradication of bovine brucellosis
is an important goal of several countries where the disease
is endemic, including Brazil that since 2001 has a national
program on the control and eradication of brucellosis and
tuberculosis (Programa Nacional de Controle e Erradicação
da Brucelose e Tuberculose – PNCEBT) [2,3].
Typing of Brucella spp. by biovar determination and
genotyping are important tools in a brucellosis control
and eradication programs [4]. Indeed, molecular typing
methods are commonly used to investigate epidemio-
logical relationships among isolates and sources ofal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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number of tandem repeats (VNTR) analysis (MLVA) has
proved to be an important tool in molecular epidemiology
studies of brucellosis [6-11], in the characterization of new
Brucella species [12] and in the evaluation of sources of
human infection [13].
In MLVA context, the assessment of the genetic stabil-
ity is one of the vital elements to guarantee the success-
ful use of this typing method, since it could confirm its
ability to differentiate between two independent strains,
while depicting relationships among strains from the
same source [14]. The genetic stability can be deduced
by typing results of multiple isolates originating from the
same strain or strains after numerous passages [8,9,15,16].
In in vitro evaluations, B. abortus vaccine and field strains
have been shown to be stable by MLVA16 [9,15-17].
Regarding to in vivo stability of the MLVA16 markers,
data based on B. abortus experimental infection showed
only few changes in the hyper-variable loci [9]. Whereas,
MLVA16 in vivo stability have not been evaluated under
natural conditions.
Therefore, the aims of this study were (i) to evaluate
the genetic diversity of B. abortus isolates obtained from
a single cattle brucellosis outbreak and (ii) to investigate
the in vivo stability of the MLVA16 markers.
Results
Serologic testing
The incidence of brucellosis in the herd between May 2009
and January 2011 is shown in Figure 1. No positive animal
was observed on three monthly tests after October 2011.Figure 1 Monthly incidence of serologically positive cattle in a bovin
Gerais, Brazil. All cattle older than 24 months were monthly tested for bru
test and the Standard Tube Agglutination Test (STAT) and 2-Mercaptoetha
until three consecutive negative herd results were obtained. The herd wa
vaccinations are highlighted with arrows).Isolation and identification
Thirty-seven isolates of B. abortus were obtained from
340 cows (375 samples) during the 16 months period of
outbreak: eight from milk samples (8% - 8/100) and
twenty-nine from post-partum vaginal swabs (10.5% -
29/275) (Table 1). Of the B. abortus isolates obtained from
vaginal swabs samples eight were associated to abortion/
stillborn occurrence. Among animals that had vaginal
swabs and milk samples collected (35 animals) three B.
abortus isolates were obtained, all from vaginal swabs.
Based on phenotypic characteristics, twenty four strains
were classified as B. abortus biovar 3 (seven from milk and
seventeen from vaginal swabs) and thirteen as B. abortus
biovar 1 (one from milk and twelve from vaginal swabs)
(Table 1). All strains classified as B. abortus biovar 3 pre-
sented smooth colonial morphology. Among the thirteen
B. abortus biovar 1 strains, twelve exhibited rough colonial
morphology and growth on tryptose agar plates supple-
mented with rifampicin (200 μg/mL) (all from vaginal
swabs), whereas one strain isolated from a milk sample
was classified as smooth Brucella spp.
All strains were confirmed as belonging to the genus
Brucella by genus-specific PCR [18], and as B. abortus by
AMOS-enhanced PCR and Bruce-ladder multiplex PCR
[19,20]. Moreover, the twelve isolates phenotypically clas-
sified as B. abortus biovar 1 rough strains were confirmed
as RB51 vaccine strain by AMOS-enhanced PCR [19].
MLVA16
The set of genetic markers which comprises the MLVA16
was observed to be stable in vivo, even when evaluatede brucellosis outbreak from May 2009 to January 2011, Minas
cellosis [Rose Bengal Plate Agglutination Test (RBPAT) as a screening
nol Test (2ME) as a confirmatory test]. Positive animals were culled
s vaccinated with RB51 on May 2009 and on December 2009 (RB51
Table 1 Clinical signs, biotyping, molecular identification and genotyping of B. abortus isolates from a bovine
brucellosis outbreak
Strain Clinical sample Collection date Biovar Genotypeb Clinical signal
1414 vaginal swab 09/01/2009 3 W Abortion
2757 vaginal swab 09/01/2009 1 RB -
2985 vaginal swab 09/01/2009 3 W -
3144 vaginal swab 10/01/2009 1 RB -
2575 vaginal swab 09/02/2009 3 W -
2558 vaginal swab 07/03/2009 1 RB -
2608 vaginal swab 08/03/2009 1 RB -
1379 vaginal swab 07/04/2009 1 RB -
3136 vaginal swab 10/05/2009 1 RB -
2634 vaginal swab 10/07/2009 3 W Abortion
1365 milk 07/27/2009 3 W Stillbirth
2476 milk 07/27/2009 3 W -
2598 milk 07/27/2009 3 W Stillbirth
2683 milk 07/27/2009 3 W -
2785 milk 07/27/2009 3 W -
2965 milk 07/27/2009 3 W -
2980 milk 07/27/2009 3 W -
3159 vaginal swab 07/27/2009 1 RB -
2922 vaginal swab 08/18/2009 1 RB -
3169 vaginal swab 08/21/2009 1 RB -
2545 vaginal swab 09/19/2009 3 W Stillbirth
2595 vaginal swab 10/17/2009 3 W -
1198 vaginal swab 10/28/2009 3 W Abortion
1219 vaginal swab 10/28/2009 3 W Abortion
2251 vaginal swab 07/11/2009 3 W -
2496 vaginal swab 07/11/2009 3 W -
2700 vaginal swab 09/11/2009 3 W Abortion
2588 vaginal swab 01/28/2010 3 W -
3238 vaginal swab 05/03/2010 3 W Stillbirth
2726 vaginal swab 03/28/2010 1 RB -
3006 vaginal swab 05/04/2010 3 W -
2998 vaginal swab 04/15/2010 3 W -
3022 vaginal swab 04/27/2010 3 W -
3016 vaginal swab 04/30/2010 3 W -
2774 vaginal swab 02/06/2010 1a Z -
2543 vaginal swab 03/11/2010 1 RB -
2850 vaginal swab 03/11/2010 1 RB -
aB. abortus biovar 1field strain.
bMLVA16 genotype.
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break. Analysis of the MLVA16 loci revealed three distinct
genotypes among the 37 B. abortus strains isolated during
the brucellosis outbreak, herein these genotypic pat-
terns were labeled RB, W and Z, for new genotypes theidentification adopted was sequential in the same way
used by Minharro et al. [11] (Table 1). The genotype RB
was observed in all twelve strains identified as B. abortus
RB51, which were all obtained from vaginal swab samples.
The genotype W was observed in all twenty four isolates
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seventeen from vaginal swabs), while genotypic profile Z
was observed in only one strain, which was isolated from
milk and identified as a smooth B. abortus biovar 1 field
strain. This biovar 1 strain was isolated eleven months
after confirmation of brucellosis in the herd on February/
2010, being one of the last strains isolated, since clinical
samples were collected until May/2010 (Table 1).
Patterns obtained in the sixteen VNTR loci are sum-
marized in Table 2. Comparison of the results observed
in the eight conserved loci included in panel 1 by Le
Flèche et al. [6] with those available in the MLVA bank
2014 (http://mlva.u-psud.fr/brucella/) showed genotypes
27, 40 and 28 for the strains classified as MLVA16
genotypes RB, W and Z, respectively. Genotype RB was
identical to the previously describe [6,16] for RB51
vaccine strain. The MLVA16 pattern for genotypes
W and Z did not find correspondence with those depos-
ited on MLVA bank 2014. In comparison with genotype
W, the genotype Z exhibited different alleles in the
loci Bruce04, Bruce06, Bruce11, Bruce16, Bruce18 and
Bruce30 (Table 2).
Discussion
Results from the present study on 37 B. abortus isolates
from milk and vaginal swabs taken from 340 cows (375
samples) during a 16 months period showed the in vivo
genetic stability of the MLVA16 markers. MolecularTable 2 Allelic types of MLVA16 loci observed for
B. abortus strains isolated from a bovine brucellosis
outbreak
Locus Tandem repeat copy numbers Number
of alleles
Panel
Genotype W Genotype Z Genotype RB
Bruce06 3 4 4 2 1
Bruce08 5 5 5 1 1
Bruce11 3 4 4 2 1
Bruce12 12 12 12 1 1
Bruce42 2 2 2 1 1
Bruce43 2 2 3 2 1
Bruce45 3 3 3 1 1
Bruce55 3 3 3 1 1
Bruce18 7 6 6 2 2A
Bruce19 42 42 42 1 2A
Bruce21 8 8 8 1 2A
Bruce04 5 3 3 2 2B
Bruce07 4 4 7 2 2B
Bruce09 3 3 3 1 2B
Bruce16 3 5 3 2 2B
Bruce30 3 6 5 3 2Btyping methods are commonly used to investigate epi-
demiological relationships among isolates and sources
of infection [5]. However, before being used for those
purposes, PCR methods for molecular typing require
careful in-house validation of typeability, reproducibility,
repeatability, stability, discriminatory power and epide-
miologic concordance [5,21]. The findings of this study,
associated with previous data on the high discriminatory
power and epidemiologic concordance of MLVA16,
besides its good typeability and in vitro stability
[6,7,9-11,13,15-17], corroborate the use of MLVA16 as
suitable typing method for refining the understanding of
the epidemiology of bovine brucellosis.
Our results showed a low genetic diversity and the
existence of three different B. abortus strains within a
focus of bovine brucellosis, the RB51 vaccine strain
(genotype RB), recovered from animals that were twice
vaccinated in the period, and two field strains (geno-
types W and Z).
In the present study no RB51 was isolated from the
milk of any animal during the post-partum period
(30–60) but only from vaginal swabs, although some
cows have been vaccinated in the last third of preg-
nancy and a highly sensitive diagnostic strategy have
been employed [22]. These results were corroborated
by previous studies that also reported no recovery of
B. abortus RB51 from any of the milk sample tested by
conventional bacteriological methods of cows vaccinated
during pregnancy or 30–60 days after delivery [23,24].
Regarding the presence of viable RB51 in postpartum
vaginal secretion, it is important to consider that all ani-
mals from which RB51 were recovered after delivery
were over 5 months of gestation by the time of revaccin-
ation with this strain and that no abortion was related
to RB51 isolation (Table 1). Thus, it is likely that the
RB51 booster had contributed to the recovery of the
vaccine strain in postpartum period, since it has been
observed that during transition period a depression in
cell-mediated response occurs, which leads to a de-
crease of the resistance to disease or increase of the re-
sidual virulence of vaccines [25].
Other important finding of this study was the demon-
stration of viable B. abortus in milk from infected ani-
mals associated with the outbreak, corroborating the
public health risk of the consumption of raw milk and
unpasteurized dairy products [26]. The colonization of
the mammary gland and associated lymph nodes by B.
abortus with excretion of microorganisms in milk was
already demonstrated [27]. In addition, it is important to
emphasize that the methodologies used for bacterial cul-
ture and molecular identification were able to differenti-
ate RB51 vaccine strain from B. abortus field strains.
Interestingly, field strains isolated from this brucel-
losis outbreak showed distinct genotypes and biotypes,
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of infection. The majority of B. abortus isolates from
the outbreak (24/25) were classified as B. abortus biovar
3 genotype W, which remained the single cause of bru-
cellosis in the herd for eleven months (from March
2009 to February 2010). This widely demonstrates that
the introduction of this strain in the herd was respon-
sible for the occurrence of the outbreak and conse-
quently for the high abortion rate observed at the end
of 2008. Furthermore, in February 2010, the introduc-
tion into the herd of another field strain, B. abortus
biovar 1 genotype Z, was observed. This genotype Z was
confirmed by a twice repetition of MLVA16 genotyping
assay that showed the same results. There are two possible
explanations for the presence of this infected animal,
negative to the conventional serological tests adopted in
the herd: first, this heifer was congenitally and persistently
infected without seroconversion [28], and second, the
negative serological result from this infected heifer was
a false negative result inherent to any diagnostic test.
However, the diagnostic strategy employed was very
sensitive [29], which tends to minimized false negative
results. Since this second field strain was represented by
just one isolate, it is very likely that the control policy
adopted in the herd, which included test-and-removal
procedures, has prevented the dissemination of this
strain to other animals and consequently a new increase
in the brucellosis prevalence levels into the herd.
Besides the differences in the classification of biovar,
the differences observed between the genotypes of the
field strains were very large and not limited to differences
in the more variable loci (Bruce04, Bruce16, Bruce18 and
Bruce30), but were also observed in conserved loci, such
as Bruce06 and Bruce11 (Table 2). Therefore, the identi-
fication of the new source of infection in the herd was
only possible due the use of MLVA16, otherwise the
genotype Z strain would have been considered just an-
other B. abortus isolate within the outbreak.
Epidemiological data of the herd also confirmed that
the B abortus biovar 1 genotype Z strain was a newly in-
troduced strain in the farm, since the young heifer from
which this strain was isolated was introduced in the herd
shortly at the end of the outbreak (November/2009). In
fact, it has been widely demonstrated that the purchase
of infected animals is the main risk factor for the intro-
duction of brucellosis in free herds [30]. Unfortunately,
it was not possible to obtain more epidemiological data
about the heifer from which the second B. abortus field
strain was isolated, such as the brucellosis status of
the herd of origin, which would have allowed a better
understanding about the epidemiology of the genotype
Z strain.
The MLVA16 panel 1 profiles of both B. abortus iso-
lates, genotypes 28 and 40 by the MLVAbank, havealready been previously observed in Minas Gerais State
[11]. Moreover, the comparison between MLVA16 geno-
types of B. abortus biovar 3 field strain (W) and those
previously described by Minharro et al. [11] revealed
differences restricted to hypervariable loci [panels 2A
(Bruce19) and 2B (Bruce04)], suggesting a possible epi-
demiological link between these strains, since all were
isolated in the state of Minas Gerais and were also iden-
tified as biovar 3. For the single field strain classified as
genotype Z, the comparison with MLVA16 patterns
previously described by Minharro et al. [11] showed a
genetic distance of one locus (Bruce19) from a B. abortus
biovar 2 also isolated from Minas Gerais State.
In a brucellosis control and eradication program the
use of an accurate surveillance and highly discrimin-
atory typing method is essential to characterize an out-
break and determine the source of infection and the
transmission routes. The present results on typing mul-
tiple B. abortus isolates from an outbreak originated
from an outbreak in the same herd depicted the in vivo
stability of the MLVA16 markers. The set of loci that
comprise the MLVA16 demonstrated to be very stable,
even when assessed over the time span of one year and
four months, since the field strain mainly responsible by
the outbreak (W) and the RB51 vaccine strain recovered
from vaccinated animals showed unchanged MLVA16
profiles. These findings are extremely important because
they definitely confirm the ability of the MLVA16 to estab-
lish correct epidemiological correlations, since, besides
having a high discriminatory power, MLVA16 markers
were also stable under natural selection pressure exerted
by the host, during the sixteen months assessed. Thus,
these results increase the confidence in the traceback
established from the results of MLVA16 and further
support this technique as the choice one for typing
B. abortus.
Futhermore, the examination of in vitro stability of the
B. abortus RB51 vaccine strain, B. abortus strain 2308
and B. abortus field isolates by serial passages in culture
medium showed no change in MLVA16 profile [9,16].
Likewise, the analysis of B. abortus S19 vaccine strain
from different batches of different manufacturers did not
reveal significant differences in MLVA16 pattern [17].
Concerning the evaluation of in vivo genetic stability of
MLVA16 loci, it has also been demonstrated that passage
of B. abortus RB51 in cattle and of B. abortus 2308 in
mouse did not lead to changes in any marker of
MLVA16 [9]. Nevertheless, minor changes in VNTR pat-
tern were observed in in vitro passages of B. abortus 544
and in genotyping of multiple B. abortus isolates from the
same outbreak [9]. Her et al. [9] found different allelic pro-
files in seven of twenty-three herds in which more than
one B. abortus isolates were obtained. Those different
genotypes from same outbreak showed mutations only
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the identification of a possible common origin of the
strains [9]. However, our data showing the high in vivo
stability of the MLVA16 loci have as main findings over
previous data the large numbers of isolates (37) ob-
tained from the same source, the long period of time
assessed (16 months) and the typing of strains coloniz-
ing different sites (mammary gland or reproductive
tract), and therefore under different selective environ-
mental pressures.
Conclusions
The results of the present study on typing of multiple
isolates from different clinical specimens originating
from the same outbreak over a sixteen month period in-
dicate the in vivo stability of the MLVA16 markers, a
low genetic diversity among B. abortus isolates and the




The experiment was conducted during an outbreak of
brucellosis in a cattle herd located in Matozinhos, Minas
Gerais, Brazil. The herd was composed of 705 Holstein
dairy cows, reared in an intensive system. All animals in
the herd were vaccinated with S19 between 3 to 8 month
of age and tested for brucellosis twice a year according
to PNCEBT [3] [Rose Bengal Plate Agglutination Test
(RBPAT) as a screening test and the Standard Tube
Agglutination Test (STAT) and 2-Mercaptoethanol Test
(2ME) as a confirmatory tests]. During 2008, several lots
of heifers were acquired in order to increase the milk
production of the herd. Prior to introduction into the
herd, all heifers were serologically tested [3] and only
lots with brucellosis-negative animals were acquired.
Suspicion of brucellosis in the herd started with an ab-
normal high abortion rate (15%) observed by the end of
2008. Brucellosis was confirmed serologically on March
2009, and a control program based on mass vaccination
with RB51 and a test-and-slaughter policy was initiated.
PNCEBT demands the compulsory S19 vaccination of
female calves aged 3 to 8 month and recommends the
voluntary RB51 vaccination of heifers older than 8 month
and cows in B. abortus infected herds. All female ani-
mals over eight months of age were revaccinated with
RB51, including pregnant heifers and cows. The herd
was revaccinated with RB51 on two different occasions:
the first in May 2009 and the second in December 2009.
Moreover, all cattle older than 24 months were monthly
tested for brucellosis (RBPAT as screening test and
STAT and 2ME as a confirmatory test) and the positive
animals were culled [3] until three consecutive negative
herd results were obtained.The experimental protocol was approved by Ethics
Committee on Animal Experimentation of Universidade
Federal de Minas Gerais (CETEA/UFMG - Protocol 139/10).
Clinical samples
Three-hundred and seventy-five clinical samples were
collected from 340 cows between January 2009 and May
2010 during the brucellosis outbreak; those included 275
vaginal swabs and 100 milk samples. Of thirty-five
animals were collected both, vaginal swabs and milk
samples. Vaginal swabs were collected in Stuart medium
from all cows immediately after abortion (twenty-two
samples) or delivery, whereas milk samples were obtained
from all cows that had 60 days or less of the last partur-
ition or abortion at 57 days after the first RB51 vaccin-
ation (07/27/2009). For each animal, 50 mL of milk was
collected after discarding of the first jet (milk from the
four quarter was mixed). Both clinical samples were
stored at -20°C until processing.
Culture conditions
Vaginal swabs were thawed and directly plated onto dupli-
cate tryptose agar plates (Difco, USA) with antibiotics
(Farrell’s selective supplement) (Oxoid, UK) [31], and they
were also inoculated in 10 mL of enrichment medium
(tryptose broth supplemented with Farrell’s selective sup-
plement) [22]. Milk samples were thawed and centrifuged
at 2500 × g, for 15 minutes. The intermediated phase was
discarded and the supernatant was mixed with the pellet.
Aliquots of 100 μL of each mixture was immediately inocu-
lated onto duplicate tryptose agar plates (Difco, USA) with
antibiotics (Farrell’s selective supplement) (Oxoid, UK) [31].
Another aliquot of 1 mL of each mixture was diluted in
9 mL of enrichment medium. The enrichment media inoc-
ulated with vaginal swabs or milk were incubated at 37°C
for seven days in 5% of CO2 and then inoculated onto tryp-
tose agar plates with antibiotics [22]. All plates were incu-
bated in 5% of CO2 at 37°C for at least 14 days [31].
Identification and biotyping of Brucella spp. isolates
Brucella spp. solates were identified to genus based on
colony morphology, positive tests for urease, catalase
and nitrate reduction, and negative tests for motility and
citrate utilization [31,32]. Classification into species and
biovar was performed by H2S production, agglutination
with sera anti-A, anti-M, anti-R and acriflavin, growth
in CO2 and O2 atmospheres and sensitivity to thionin
(20 μg/mL and 40 μg/mL), basic fuchsin (20 μg/mL),
and rifampicin (200 μg/mL) [31-33].
Suspected Brucella spp. colonies were also suspended in
100 μL of Tris EDTA (10 mM Tris–HCl, 1 mM EDTA,
pH 8.0), inactivated at 85°C for 2 hours and subjected to
genomic DNA extraction [34]. DNA quality and concen-
tration were determined by spectrophotometry [35].
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the gene bcsp31 [18] and AMOS-enhanced PCR [19] were
also used for identification of isolates [see Additional
file 1: Table S1]. Since B. abortus biovar 3 strains are
not identified by AMOS-enhanced PCR, these strains
were also analyzed by Bruce-ladder multiplex PCR [20] to
confirm their identification as B. abortus [see Additional
file 1: Table S1].
Reference strains, used as control in different procedures,
were: B. abortus biovar 1 544 =ATCC 23448T; B. abortus
biovar 2 ATCC 23449; B. abortus biovar 3 Tulya =ATCC
23450; B. abortus biovar 4 292 =ATCC 23451; B. abortus
biovar 5 3196 =ATCC 23452; B. abortus biovar 6 870 =
ATCC 23453; B. abortus biovar 9 C68 = ATCC 23455;
B. abortus biovar 1 S19; B. abortus biovar 1 RB51; B.
melitensis biovar 1 16 M = ATCC 23456T; B. ovis Reo
198; B. suis biovar 1 1330 =ATCC 23444; Escherichia coli =
ATCC 25922; E. coli B41; Listeria monocytogenes=ATCC
19115; Pseudomonas aeroginosa = ATCC 27853; Sal-
monella enterica serovar Typhimurium = ATCC 14028;
and Staphylococcus aureus = ATCC 29213.
MLVA 16 genotyping
DNA from each strain was genotyped by a subset of 16
tandem repeat loci (MLVA16) as previously described [6,7]
[see Additional file 1: Table S1]. The method analyses 16
VNTR loci divided into three panels: panel 1 composed of
eight minisatellites (Bruce06, Bruce08, Bruce11, Bruce12,
Bruce42, Bruce43, Bruce45 and Bruce55); panel 2A com-
posed of three microsatellites (Bruce18, Bruce19 and
Bruce21); and panel 2B with five microsatellites (Bruce04,
Bruce07, Bruce09, Bruce16 and Bruce30) [6,7].
The amplified products were submitted to electrophor-
esis in 2% or 3% agarose gel, for the mini and microsatel-
lites, respectively, in Tris-borate-EDTA 1X (TBE) buffer,
stained with 0.5 mg/mL ethidium bromide, visualized
under UV light, and photographed (ImageMaster VDS,
Phamarcia Biotech, Sweden). DNA size markers 100 bp
(100 bp DNA Ladder, New England Biolabs, USA) and
25 bp (25 bp DNA Step Ladder, Promega, USA) were used
to estimate the tandem repeat unit length.
Each estimated band size was converted into number of
repeat units for each locus, with aid of the software BioNu-
merics 5.1 (Applied Maths, Belgium), as described [6]. Clus-
tering analysis was performed using the same software based
on the category coefficient and the unweighted pair group
method with arithmetic mean (UPGMA) algorithm [6].
Additional file
Additional file 1: Table S1. Primers used in the present study.
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